Mental HealthICD-10: F31.9Affects approximately 2.8% of U.S. adults

Bipolar Disorder

Also known as: Manic-Depressive Illness, Bipolar Affective Disorder, Manic Depression

Bipolar disorder is a chronic mental health condition characterized by extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). These episodes can affect sleep, energy, behavior, judgment, and the ability to think clearly. With appropriate treatment including mood stabilizers and psychotherapy, most people with bipolar disorder can manage their symptoms and lead productive lives.

Last updated November 10, 2026

Understanding Bipolar Disorder

Bipolar disorder is a lifelong mood condition in which periods of abnormally elevated energy and mood (mania in bipolar I, the milder hypomania in bipolar II) alternate with episodes of depression, usually with stretches of normal mood in between. In the US National Comorbidity Survey Replication, about 1 percent of adults met criteria for bipolar I, 1.1 percent for bipolar II and a further 2.4 percent for subthreshold forms, which is where the often-quoted figure of 2.8 percent of adults in any given year comes from. It affects men and women about equally, typically begins between 15 and 25, and runs strongly in families: twin studies put heritability at 60 to 85 percent. The average delay from first symptoms to the correct diagnosis is 6 to 10 years, mostly because people seek help when depressed and are treated for ordinary depression. The stakes are high: 25 to 50 percent of people attempt suicide at some point, and life expectancy is shortened by 10 to 13 years, mainly through cardiovascular disease rather than suicide.

Nobody has found a single chemical imbalance to correct. What is known is that bipolar disorder involves unstable regulation of circadian rhythm, reward circuits and stress hormones, and that sleep loss is both an early symptom and a reliable trigger of mania: one or two nights without sleep, whether from travel, a new baby or a deadline, can tip a vulnerable person into an episode. The illness is also far more depressive than its name suggests. In a 13-year NIMH follow-up of 146 people with bipolar I, participants had mood symptoms during 47 percent of weeks, and depressive symptoms were three times as common as manic or hypomanic ones; in bipolar II the ratio was nearly 40 to 1. Episodes recur: roughly 90 percent of people who have one manic episode go on to have more, and about half relapse within a year of stopping maintenance treatment. Each episode also appears to make the next more likely and harder to treat, which is why early, sustained treatment matters.

Mood stabilizers are the foundation of treatment, and every major guideline (the American Psychiatric Association, NICE and the 2018 CANMAT/ISBD guideline) places lithium first for long-term prevention. Lithium is the only drug shown to reduce suicide in bipolar disorder: a 2013 BMJ meta-analysis of 48 randomized trials found it cut suicide deaths by more than 60 percent compared with placebo. In the BALANCE trial of 330 people, lithium alone or with valproate prevented relapse better than valproate alone. Lithium needs blood monitoring, with maintenance levels usually 0.6 to 0.8 mmol/L and creatinine, eGFR, TSH and calcium checked every 6 to 12 months. Quetiapine, lurasidone, cariprazine, lumateperone and lamotrigine treat or prevent bipolar depression; valproate and the antipsychotics treat mania. Antidepressants on their own are a different matter: in the STEP-BD trial of 366 people, adding one to a mood stabilizer was no better than placebo, and used alone they can trigger mania or rapid cycling. Added psychotherapy roughly halves relapse rates; group psychoeducation, family-focused therapy, CBT and interpersonal and social rhythm therapy all have randomized trial support.

No supplement treats mania, and nothing natural replaces a mood stabilizer; the honest ceiling is Moderate evidence for omega-3 in the depressive phase. A 2012 meta-analysis of six randomized trials found EPA-rich fish oil produced a small to moderate improvement in bipolar depression scores when added to standard medication, with no effect on mania. N-acetylcysteine looked promising in a 24-week trial of 75 people but failed to beat placebo in a larger 2019 trial. Folate, inositol, vitamin D and melatonin each have one or two small or mixed trials, mostly as add-ons for depression or sleep. Several popular products are actively risky. St John's wort can trigger mania, combines with SSRIs to cause serotonin syndrome, and speeds the breakdown of quetiapine, aripiprazole, lurasidone and many other drugs through the CYP3A4 enzyme. SAM-e and 5-HTP have also induced mania in case series, and high-dose omega-3 (4 g a day or more) raises bleeding risk with anticoagulants and has been linked to atrial fibrillation in cardiology trials. Tell your prescriber about every supplement you take.

The most common mistake is stopping medication when well. Mania often feels productive rather than ill, depression lifts, and the pills seem to be the only thing left to blame for weight gain, tremor or feeling flat, so people taper or quit. The results are predictable: after abrupt lithium withdrawal, about half of people relapse within 5 months, and a relapse after stopping is not reliably reversed by restarting. If side effects are the problem, the fix is a dose change or a switch negotiated with the prescriber over weeks, never a sudden stop. The second mistake is treating a depressive episode as if it were ordinary depression, with an antidepressant and no mood stabilizer, which risks a switch into mania. If you or someone you love is in crisis, severely depressed, hearing voices or talking about suicide, call or text 988 (the Suicide and Crisis Lifeline) or go to the nearest emergency department; mania with psychosis, several days without sleep or dangerous behavior is a psychiatric emergency.

At a Glance

Common symptoms
Manic episodes: elevated mood, increased energy, decreased sleep need, Grandiosity or inflated self-esteem during mania, Racing thoughts and rapid speech
Main treatments
Mood stabilizers (lithium, valproate, lamotrigine), Atypical antipsychotics (quetiapine, olanzapine, aripiprazole), Antidepressants (used cautiously, usually with a mood stabilizer)
Category
Mental Health · Affects approximately 2.8% of U.S. adults
See a doctor if
You experience extreme mood swings that affect your relationships or work

Symptoms

Manic episodes: elevated mood, increased energy, decreased sleep need
Grandiosity or inflated self-esteem during mania
Racing thoughts and rapid speech
Impulsive or risky behavior (excessive spending, sexual indiscretions)
Depressive episodes: persistent sadness, hopelessness
Loss of interest in previously enjoyed activities
Fatigue and slowed movements during depression
Difficulty concentrating and making decisions
Suicidal thoughts during depressive episodes

Causes

  • Genetic factors (strong hereditary component)
  • Neurochemical imbalances in the brain
  • Structural and functional brain differences
  • Stressful or traumatic life events as triggers

Risk Factors

  • Family history of bipolar disorder (first-degree relative increases risk 10x)
  • High-stress environments or major life changes
  • Substance abuse
  • Age of onset typically between 15 and 25
  • History of childhood trauma or abuse

Diagnosis

  • Comprehensive psychiatric evaluation
  • Mood charting and symptom tracking over time
  • DSM-5 criteria (at least one manic or hypomanic episode)
  • Blood tests and imaging to rule out medical causes
  • Screening for co-occurring conditions (anxiety, substance use)

Treatment

  • Mood stabilizers (lithium, valproate, lamotrigine)
  • Atypical antipsychotics (quetiapine, olanzapine, aripiprazole)
  • Antidepressants (used cautiously, usually with a mood stabilizer)
  • Psychotherapy (CBT, interpersonal and social rhythm therapy)
  • Psychoeducation for patients and families
  • Electroconvulsive therapy (ECT) for treatment-resistant cases

Natural remedies for bipolar disorder: what the evidence says

Ranked by the strength of human evidence for bipolar disorder specifically. These sit alongside medical care, not in place of it.

  1. A 2012 meta-analysis of six randomized trials found that adding omega-3 to standard medication improved bipolar depression with a moderate effect size (Hedges g 0.34) and had no effect on mania. In the best single trial, 75 people on stable medication who added 1 or 2 g of EPA daily for 12 weeks improved more on depression scales than placebo, while a 4-month trial of 6 g EPA in 116 people found no benefit, so more is not better. Benefits, when present, appear after 8 to 12 weeks.

    Studied dose
    1 to 2 g of EPA daily from an EPA-predominant fish oil, added to prescribed treatment, for at least 12 weeks.
    Cautions
    At 1 to 2 g daily it is compatible with lithium and antipsychotics. Doses of 4 g or more increase bleeding with warfarin, apixaban, aspirin and clopidogrel and were linked to new atrial fibrillation in large cardiology trials; stop before surgery and tell your prescriber.
  2. N-Acetylcysteine

    Preliminary evidence

    In a 24-week placebo-controlled trial of 75 people with bipolar disorder, 2 g of N-acetylcysteine daily added to usual treatment lowered depression scores by about 8 points more than placebo, with most of the effect in the final weeks. A larger 16-week trial of 181 people with bipolar depression published in 2019 found no difference from placebo, so the evidence is mixed and any benefit is for depressive symptoms only.

    Studied dose
    1,000 mg twice daily (2 g a day) for at least 16 to 24 weeks, as an add-on.
    Cautions
    Nausea and heartburn are common; rare asthma flare. It may add to the effect of anticoagulants and should be stopped before surgery. Not a treatment for mania.
  3. Folate

    Preliminary evidence

    Low folate is common in bipolar depression. In an 88-person trial, 3 mg of folic acid added to valproate improved mania scores more than placebo over 3 weeks, and an older British trial found 200 mcg daily added to lithium reduced mood symptoms in people whose folate levels rose. However, in the 2016 CEQUEL trial of 202 people with bipolar depression, folic acid 500 mcg appeared to cancel out the benefit of lamotrigine, so it should not be combined with that drug without advice.

    Studied dose
    400 to 800 mcg daily of folic acid or L-methylfolate; ask for a serum folate and vitamin B12 first.
    Cautions
    Avoid with lamotrigine (reduced effect in CEQUEL). High doses mask vitamin B12 deficiency, so check B12 first. Interacts with methotrexate and some seizure medicines.
  4. Inositol

    Preliminary evidence

    Inositol is a second messenger in the same signaling pathway that lithium acts on. In the STEP-BD comparison of 66 people with treatment-resistant bipolar depression, recovery rates were 17 percent with inositol, 24 percent with lamotrigine and 5 percent with risperidone, with no statistically significant difference among them. Two earlier placebo-controlled trials of 12 g daily (24 and 17 people) showed trends toward improvement that did not reach significance.

    Studied dose
    6 to 12 g myo-inositol powder daily in divided doses, as an add-on, for 6 to 8 weeks.
    Cautions
    Loose stools and gas at higher doses. Case reports of mania when used alone, so only with a mood stabilizer and with your prescriber's knowledge.
  5. Vitamin D

    Preliminary evidence

    Low vitamin D is common in bipolar disorder and linked to worse depression in observational studies, but trial data are thin: a 12-week placebo-controlled trial of 5,000 IU daily in 33 adults with bipolar depression found no significant difference, while an 8-week open-label study of 2,000 IU in 16 adolescents reduced both manic and depressive symptoms. Correcting a measured deficiency is sensible for bone and general health regardless.

    Studied dose
    1,000 to 2,000 IU vitamin D3 daily, or a dose chosen after a 25-hydroxyvitamin D test.
    Cautions
    Doses above 4,000 IU daily without testing can raise calcium; lithium itself can raise calcium and parathyroid hormone, so have calcium checked if you take both.
  6. Melatonin

    Preliminary evidence

    Protecting sleep is central to staying well, and melatonin has been studied mainly for that. Small, mostly open-label studies of 3 to 12 mg in people with bipolar disorder reported better sleep without mood switching, but a 2015 systematic review found no good evidence that it prevents relapse. It is most useful for resetting the clock after travel or shift changes, when sleep loss would otherwise be a mania trigger.

    Studied dose
    0.5 to 3 mg, 1 to 2 hours before a fixed bedtime; higher doses are not more effective.
    Cautions
    Can increase bleeding with warfarin, and fluvoxamine multiplies its blood levels; grogginess the next morning at higher doses. Not a substitute for a regular sleep schedule.

What matters day to day

  • Keep the same wake time and bedtime every day, including weekends, and protect 7 to 9 hours: sleep loss is the most reliable trigger of mania, and interpersonal and social rhythm therapy, built around stable daily routines, lengthened time to relapse in a trial of 175 people.
  • Learn your relapse signature and write a plan: in a randomized trial of 69 people, teaching early warning signs (needing less sleep, talking faster, spending more) cut manic relapses by 30 percent and pushed the time to a first manic relapse from 17 weeks to 65 weeks.
  • Avoid alcohol and cannabis entirely: about 40 percent of people with bipolar disorder develop an alcohol use disorder, and cannabis use is associated with earlier onset, more manic episodes and poorer response to medication.
  • Walk, cycle or lift for 150 minutes a week and have weight, blood pressure, A1c and lipids checked yearly: people with bipolar disorder die 10 to 13 years early, mostly of heart disease, and many of the medications add weight.
  • Keep caffeine steady and under about 400 mg a day: it fragments sleep, and because caffeine increases lithium clearance, suddenly cutting it out can raise lithium levels by around a quarter.
  • Bring one trusted person into the plan: family-focused therapy, which teaches relatives to spot episodes early and lower conflict, reduced relapses over 2 years in trials and is what works when insight is lost during mania.

Prevention

  • Take prescribed medications consistently, even when feeling well
  • Maintain a regular sleep schedule
  • Avoid alcohol and recreational drugs
  • Monitor mood patterns and recognize early warning signs
  • Build a strong support system

When to See a Doctor

  • You experience extreme mood swings that affect your relationships or work
  • You feel invincible or need very little sleep for days
  • You have persistent depressive symptoms or feelings of hopelessness
  • You or someone you know has thoughts of self-harm or suicide—call 988

Frequently Asked Questions

References

  1. Judd LL, Akiskal HS, Schettler PJ, et al.. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry (2002)
  2. Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ (2013)
  3. Geddes JR, Goodwin GM, Rendell J, et al.. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet (2010)
  4. Sachs GS, Nierenberg AA, Calabrese JR, et al.. Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine (2007)
  5. Yatham LN, Kennedy SH, Parikh SV, et al.. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders (2018)
  6. Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. Journal of Clinical Psychiatry (2012)
  7. Berk M, Copolov DL, Dean O, et al.. N-acetyl cysteine for depressive symptoms in bipolar disorder: a double-blind randomized placebo-controlled trial. Biological Psychiatry (2008)
  8. Geddes JR, Gardiner A, Rendell J, et al.. Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2x2 factorial randomised trial. Lancet Psychiatry (2016)
  9. Perry A, Tarrier N, Morriss R, et al.. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ (1999)
  10. National Institute of Mental Health. Bipolar Disorder (2024)View source

Related Conditions

Related from the Supplement Library

These supplements have been studied in relation to Bipolar Disorder. Always consult your healthcare provider before starting any supplement, especially if you take medications.

Related Reading

Have questions about Bipolar Disorder?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.